Delivery Order SPE2DB22D9309-SPE2DB25FAF41
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $7,531.89 with an ultimate completion date of September 2, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,021.26 for EXPAREL 1.3% 20ML (10 units) on August 18, 2025. This firm fixed-price delivery order was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The awardee will perform this delivery at its Park Ridge, Illinois location, with an ultimate completion date of August 18, 2025....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $25,106.30 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries an ultimate completion date of September 5, 2025, and involves no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for EXPAREL 266 mg/20 mL vials valued at $2,510.63. The contract is classified as firm fixed-price with an ultimate completion date of September 10, 2025. This delivery order was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive standing in the federal procurement market. The place...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,414.04 by the Defense Logistics Agency (DLA) on September 2, 2025. The contract calls for delivery of EXPAREL 133 mg/10 ml vials, a local anesthetic medication used in surgical and pain management applications. The delivery is scheduled for completion by September 23, 2025, with performance taking place at the vendor's...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The contract was awarded on August 25, 2025, with a firm fixed-price ceiling value of $6,028.88 and an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $37,659.45 for the supply of EXPAREL 266 mg/20 mL vials. The award, made on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $5,021.26 for EXPAREL 1.3% 20ML (10 units) by the Defense Logistics Agency's Medical Supply Chain. The contract was awarded on July 31, 2025, with an ultimate completion date of the same day, and carries no set-aside designation. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and...
- SPE2DB22D9309Indefinite Delivery Contract
- SPE2DB22D9309-SPE2DB25FAF41Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of EXPAREL 133 mg/10 mL vials. The contract is valued at $6,092.20 with a firm fixed-price structure and an ultimate completion date of September 23, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis. The place of performance is located in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA valued at $500 million and valid through November 2026. The IDC enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products to support medical supply needs for military healthcare facilities worldwide. EXPAREL, a liposomal bupivacaine formulation, is a local anesthetic used in surgical and medical settings. Through this established contract vehicle, DMS Pharmaceutical Group continues to serve as a critical supplier within the federal pharmaceutical supply chain, providing prescription drugs and pharmaceutical products directly to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 9/2/25 |